ONCO (STOCKS)
Onconetix, Inc. Common Stock
$0.958000
-0.892000 (-48.22%)
Prev close: $1.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Karina M. Fedasz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1.65M
- Employees
- 5
- P/E (TTM)
- —
- P/B (TTM)
- 0.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$0.25 | $0.00 | +0.0000 | +0.00% |
|
Sep 2023 (Q3)
|
$-918.00 | $-658.92 | -259.0800 | -39.32% |
|
Jun 2023 (Q2)
|
$-714.00 | $-520.20 | -193.8000 | -37.25% |
|
Mar 2023 (Q1)
|
$-612.00 | $-728.28 | +116.2800 | +15.97% |
Financial Statements
| Revenues | $1.22M |
| Benefits Costs and Expenses | $51.28M |
| Cost Of Revenue | $178.55K |
| Costs And Expenses | -$10.94M |
| Gross Profit | $1.05M |
| Nonoperating Income/Loss | -$4.34M |
| Operating Expenses | $46.77M |
| Selling, General, and Administrative Expenses | $8.17M |
| Depreciation and Amortization | $131.13K |
| Other Operating Expenses | $38.31M |
| Operating Income/Loss | -$45.72M |
| Income/Loss From Continuing Operations After Tax | -$49.14M |
| Income/Loss From Continuing Operations Before Tax | -$50.06M |
| Net Income/Loss | -$49.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$49.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.70M |
| Preferred Stock Dividends And Other Adjustments | $1.70M |
| Basic Earnings Per Share | $3.03K |
| Diluted Earnings Per Share | $3.03K |
| Basic Average Shares | 3,463,504 |
| Diluted Average Shares | 3,463,504 |
| Assets | $19.68M |
| Current Assets | $1.30M |
| Inventory | $151.56K |
| Other Current Assets | $1.15M |
| Noncurrent Assets | $18.38M |
| Fixed Assets | $40.39K |
| Other Non-current Assets | $18.34M |
| Liabilities | $16.30M |
| Current Liabilities | $16.30M |
| Accounts Payable | $1.80M |
| Other Current Liabilities | $14.50M |
| Noncurrent Liabilities | $0.00 |
| Equity | $3.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.37M |
| Liabilities And Equity | $19.68M |
| Net Cash Flow From Operating Activities | -$7.51M |
| Net Cash Flow From Operating Activities, Continuing | -$7.51M |
| Net Cash Flow From Investing Activities | -$193.93K |
| Net Cash Flow From Investing Activities, Continuing | -$1.32M |
| Net Cash Flow From Financing Activities | $9.21M |
| Net Cash Flow From Financing Activities, Continuing | $9.21M |
| Exchange Gains/Losses | -$1.20M |
| Net Cash Flow | $1.43M |
| Net Cash Flow, Continuing | $2.64M |
| Comprehensive Income/Loss | -$50.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$50.70M |
| Other Comprehensive Income/Loss | -$50.70M |